Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Aimovig, Alcami, altered, AMT, antibody, APOLLO, Asia, assumption, atogepant, Auxilium, Aviron, BBA, Biohaven, Bipartisan, BLA, BMI, Boulevard, built, Cadillac, California, CentreOne, chain, Charleston, chemotherapy, Chesterbrook, colorectal, comorbid, confusion, constitute, cyber, deliberate, Diego, digital, domain, domestic, donut, Duke, Elderly, Engineering, eptinezumab, erenumab, Eurasia, excise, fellow, fremanezumab, Fuqua, galcanezumab, Geoghegan, Germantown, goodwill, grow, gynecologic, halt, halted, heightened, hole, immune, inflammatory, insource, insourcing, Jonathan, KS, landlord, McPherson, MedImmune, modification, Nabriva, NC, neuropathic, neuropathy, Northeastern, obese, orthopedic, outsource, outsourcing, overhead, passed, passing, PCAOB, readout, relocation, remeasurement, resolution, rimegepant, San, Savient, saving, sc, Semprana, sophistication, stranded, suppression, thereof, tradename, tramadol, twelve, uncertainty, undertaken, unimproved, Villanova, Violin, WI, Wilmington, workforce, Wyeth
Removed:
activate, advanced, Affordability, afterload, amend, assessing, augment, blood, Calculating, cardiology, catheterization, cellular, Centocor, collection, Concert, concomitant, confirmed, Cooperation, coupled, creatinine, crystalline, curve, designing, displace, diuretic, dobutamine, Durect, dysfunction, dyspnea, ejection, electroencephalogram, elucidation, emergency, Eurasian, Explorer, facilitating, filtration, flow, fluid, footage, forcefully, founded, founder, fraction, fragile, France, function, furosemide, Germany, GFR, glomerular, goal, GPCR, implicated, intracardiac, intravascular, Italy, Johnson, Lark, leading, living, loop, Michael, Microbiology, moderate, molecular, morbidity, mortality, moving, Musculoskeletal, nitroglycerin, occupy, organism, payroll, persuade, pharmacological, Philadelphia, predicted, preload, Prize, pumped, readmission, redeemable, renin, resale, revaluation, revise, RPF, selecting, sensitivity, signal, Soergel, Spain, specificity, spectrum, stable, stimulating, suboptimal, surface, survey, systolic, transdermal, transplant, Treaty, ultimate, underwent, unique, upper, Urogenital, West
Filing tables
Filing exhibits
Related press release
Associated TRVN transcripts
TRVN similar filings
Filing view
External links
Exhibit 12.1
TREVENA, INC.
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
2013 | 2014 | 2015 | 2016 | 2017 | |||||||||||||||
(in thousands) | |||||||||||||||||||
Determination of earnings | |||||||||||||||||||
Income/(loss) before income taxes | $ | (23,251 | ) | $ | (49,701 | ) | $ | (50,528 | ) | $ | (102,994 | ) | $ | (71,865 | ) | ||||
Add: | |||||||||||||||||||
Fixed Charges | 303 | 234 | 531 | 1,927 | 3,232 | ||||||||||||||
Total Earnings/(loss) | (22,948 | ) | (49,467 | ) | (49,997 | ) | (101,067 | ) | (68,633 | ) | |||||||||
Fixed charges: | |||||||||||||||||||
Interest expense and amortization of debt discount and deferred financing costs | 150 | 71 | 334 | 1,738 | 2,781 | ||||||||||||||
Estimated interest component of rent expense | 153 | 163 | 197 | 189 | 541 | ||||||||||||||
Total fixed charges | 303 | 234 | 531 | 1,927 | 3,322 | ||||||||||||||
Ratio of earnings to fixed charges(1) | |||||||||||||||||||
Deficiency of earnings to cover fixed charges | $ | 23,251 | $ | 49,701 | $ | 50,528 | $ | 102,994 | $ | 71,865 |
____________________________________________
(1) For all periods presented, no ratios are provided as earnings were insufficient to cover fixed charges.